SM200300009B - Composizione e suo uso terapeutico - Google Patents

Composizione e suo uso terapeutico

Info

Publication number
SM200300009B
SM200300009B SM200300009A SM200300009A SM200300009B SM 200300009 B SM200300009 B SM 200300009B SM 200300009 A SM200300009 A SM 200300009A SM 200300009 A SM200300009 A SM 200300009A SM 200300009 B SM200300009 B SM 200300009B
Authority
SM
San Marino
Prior art keywords
composition
therapeutic use
therapeutic
Prior art date
Application number
SM200300009A
Other languages
English (en)
Other versions
SM200300009A (it
Inventor
Mishal Hamid Al-Sari
Original Assignee
Insignion Holdings Ltd
Veritron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insignion Holdings Ltd, Veritron Ltd filed Critical Insignion Holdings Ltd
Publication of SM200300009A publication Critical patent/SM200300009A/it
Publication of SM200300009B publication Critical patent/SM200300009B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
SM200300009A 2002-05-29 2003-05-29 Composizione e suo uso terapeutico SM200300009B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0212405.5A GB0212405D0 (en) 2002-05-29 2002-05-29 Composition and its therapeutic use

Publications (2)

Publication Number Publication Date
SM200300009A SM200300009A (it) 2004-12-01
SM200300009B true SM200300009B (it) 2004-12-01

Family

ID=9937661

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200300009A SM200300009B (it) 2002-05-29 2003-05-29 Composizione e suo uso terapeutico

Country Status (30)

Country Link
EP (2) EP1513546A1 (it)
JP (3) JP4362441B2 (it)
CN (3) CN1655811A (it)
AP (1) AP2004003177A0 (it)
AR (1) AR039895A1 (it)
AT (1) ATE468134T1 (it)
AU (4) AU2003236893A1 (it)
BR (1) BR0311371A (it)
CA (1) CA2487678A1 (it)
DE (1) DE60332578D1 (it)
EA (1) EA010548B1 (it)
EC (1) ECSP045458A (it)
GB (3) GB0212405D0 (it)
IL (1) IL164952A0 (it)
IS (1) IS7578A (it)
MA (1) MA27207A1 (it)
ME (1) MEP22908A (it)
MX (1) MXPA04011794A (it)
MY (2) MY139933A (it)
NO (1) NO20044768L (it)
NZ (1) NZ536360A (it)
OA (1) OA12862A (it)
PL (1) PL374199A1 (it)
RS (1) RS102304A (it)
SM (1) SM200300009B (it)
TN (1) TNSN04235A1 (it)
TW (1) TW200425892A (it)
UY (1) UY27827A1 (it)
WO (1) WO2003101479A1 (it)
ZA (2) ZA200210316B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212405D0 (en) * 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use
GB0501654D0 (en) * 2005-01-26 2005-03-02 Veritron Ltd Stabilised plant extract
GB0523257D0 (en) * 2005-11-15 2005-12-21 Veritron Ltd Purification process
GB0710536D0 (en) 2007-06-01 2007-07-11 Veritron Ltd Plant extract and its therapeutic use
DE102007030103A1 (de) * 2007-06-28 2009-01-02 Bode Chemie Gmbh & Co. Kg Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
GB0808974D0 (en) * 2008-05-16 2008-06-25 Veritron Ltd Plant extract and its therapeutic use
EP2420228A1 (en) 2010-08-05 2012-02-22 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
JP5756326B2 (ja) * 2011-04-14 2015-07-29 一丸ファルコス株式会社 キネシン抑制剤
CN104302670A (zh) 2012-02-07 2015-01-21 Phi生物医药股份有限公司 制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体
CN105722500B (zh) * 2013-09-11 2019-08-30 伊戈尔生物药品股份有限公司 包含离子性液体的液体蛋白质制剂
MX2017004306A (es) 2014-10-01 2017-12-20 Eagle Biologics Inc Formulaciones de polisacáridos y ácido nucleico que contienen agentes de reducción de viscosidad.
FR3057773B1 (fr) 2016-10-21 2020-06-19 Universite Claude Bernard Lyon 1 Nouvelles compositions antivirales pour le traitement des infections liees aux coronavirus
AU2021351504A1 (en) * 2020-09-30 2023-05-25 Reven Pharmaceuticals Inc. Pharmaceutical compositions and methods for prevention and/or treatment of inflammation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
FR2126134A1 (en) * 1971-02-26 1972-10-06 Ates Ibrahim Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
JPH02144075A (ja) * 1988-11-25 1990-06-01 Olympus Optical Co Ltd 薬剤放出装置
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
JP2902886B2 (ja) * 1992-12-28 1999-06-07 三洋電機株式会社 記録ディスク演奏装置
CA2112539A1 (en) * 1993-12-29 1995-06-30 Romualdo D. Candelario Medicated herbal lotion
IT1269826B (it) * 1994-05-24 1997-04-15 Paolo Minoia Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
JPH08176002A (ja) * 1994-12-27 1996-07-09 Kao Corp 細胞接着抑制剤
US5639787A (en) * 1995-02-28 1997-06-17 The Center For The Improvement Of Human Functioning Int'l, Inc. Therapeutic method for the treatment of cancer
DK0802257T3 (da) * 1996-04-19 2002-10-28 Nestle Sa Udødeliggjort cellelinie fra epitelceller i human colon
US6692961B1 (en) * 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
JP2000086510A (ja) * 1998-09-16 2000-03-28 Oriza Yuka Kk ヒスタミン遊離抑制剤
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
EP1223928A2 (en) * 1999-07-08 2002-07-24 Patrick Thomas Prendergast Use of flavones, coumarins and related compounds to treat infections
ES2310941T3 (es) * 1999-08-30 2009-01-16 The Ester C Company Utilizaciones y composiciones para la quimioterapia selectiva destinada al cancer.
WO2001035943A2 (en) * 1999-11-15 2001-05-25 Gangal Hanamaraddi T Dextrose and insulin fluid formulation for intravenous infusion
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
AU2000231423A1 (en) * 2000-03-03 2001-09-12 Shu-Wen Lee Specific therapeutic composition for treating aids
EP1195159B1 (en) * 2000-10-09 2006-05-31 Rath, Matthias, Dr. med. Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer
GB0212405D0 (en) * 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use

Also Published As

Publication number Publication date
CA2487678A1 (en) 2003-12-11
CN101380463A (zh) 2009-03-11
AU2007203159B2 (en) 2009-03-26
NZ536360A (en) 2008-03-28
CN1466994A (zh) 2004-01-14
MY134288A (en) 2007-11-30
ZA200210316B (en) 2003-07-04
EA200401586A1 (ru) 2005-04-28
IL164952A0 (en) 2005-12-18
SM200300009A (it) 2004-12-01
AP2004003177A0 (en) 2004-12-31
UY27827A1 (es) 2003-12-31
GB0615918D0 (en) 2006-09-20
TNSN04235A1 (en) 2007-03-12
MEP22908A (en) 2010-06-10
GB2392618B (en) 2007-02-21
MA27207A1 (fr) 2005-01-03
AU2007203159A1 (en) 2007-07-26
CN1655811A (zh) 2005-08-17
AU2009200893A1 (en) 2009-04-09
IS7578A (is) 2004-12-01
ZA200409551B (en) 2005-10-11
AU2003204391B2 (en) 2005-08-04
AU2003236893A1 (en) 2003-12-19
NO20044768L (no) 2005-02-24
BR0311371A (pt) 2005-04-05
PL374199A1 (en) 2005-10-03
ECSP045458A (es) 2005-05-30
TW200425892A (en) 2004-12-01
OA12862A (en) 2006-09-15
GB2392618A (en) 2004-03-10
DE60332578D1 (de) 2010-07-01
JP2004002429A (ja) 2004-01-08
GB2427824A (en) 2007-01-10
EP1366768B1 (en) 2010-05-19
AU2003204391A1 (en) 2003-12-18
JP2006500324A (ja) 2006-01-05
GB0212405D0 (en) 2002-07-10
MXPA04011794A (es) 2005-07-05
RS102304A (en) 2006-12-15
JP4362441B2 (ja) 2009-11-11
MY139933A (en) 2009-11-30
EA010548B1 (ru) 2008-10-30
EP1513546A1 (en) 2005-03-16
JP2009143947A (ja) 2009-07-02
AR039895A1 (es) 2005-03-09
ATE468134T1 (de) 2010-06-15
WO2003101479A1 (en) 2003-12-11
GB0325839D0 (en) 2003-12-10
EP1366768A1 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
CY2018009I2 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
DK3536344T3 (da) Superfin formoterolformulering
CY2014001I1 (el) Συνδυασμος αζελαστινης και φλουτικαζονης
NO20050132D0 (no) Vaksinesammensetning
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
DE10393374D2 (de) Zusammensetzung
DE60305827D1 (de) Polierzusammensetzung
NO20051956D0 (no) Salmeterol superfin formulering
SE0500163L (sv) Sammansättning
NO20050689L (no) Terapeutisk anvendelse
DK1596870T3 (da) Höjdosis-iblandronatformulering
SM200300009A (it) Composizione e suo uso terapeutico
DE60322926D1 (de) Photopolymerisierbare zusammensetzung und verwendung davon
DE60321641D1 (de) Photopolymerisierbare Initiatorkombination und photopolymerisierbare Zusammensetzung
NO20044106L (no) Omkonstruerte baculoviruser og anvendelse derav
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
NO20044140D0 (no) New Composition
DK1680134T3 (da) Sammensætninger og anvendelser deraf
NO20053898D0 (no) Use and proceeding at footballshoes
SE0302396L (sv) A novel deicing composition and use thereof
SE0100590D0 (sv) New composition and use
ITMI20020039A1 (it) Composizioni comprendenti colostro e loro uso
FR2850276B1 (fr) Composition anti-exsudante et/ou anti-desquamante et/ou anti-exfoliante